KalVista Pharmaceuticals (KALV) Equity Ratio (2016 - 2024)
Historic Equity Ratio for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to 0.56.
- KalVista Pharmaceuticals' Equity Ratio changed N/A to 0.56 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.56, marking a year-over-year change of. This contributed to the annual value of 0.88 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Equity Ratio is 0.56.
- In the past 5 years, KalVista Pharmaceuticals' Equity Ratio ranged from a high of 0.91 in Q2 2020 and a low of 0.56 during Q4 2024
- Moreover, its 4-year median value for Equity Ratio was 0.87 (2023), whereas its average is 0.83.
- Data for KalVista Pharmaceuticals' Equity Ratio shows a peak YoY increase of 1053.19% (in 2020) and a maximum YoY decrease of 130.0% (in 2020) over the last 5 years.
- Over the past 4 years, KalVista Pharmaceuticals' Equity Ratio (Quarter) stood at 0.86 in 2020, then rose by 2.71% to 0.88 in 2021, then dropped by 6.75% to 0.82 in 2023, then tumbled by 32.41% to 0.56 in 2024.
- Its last three reported values are 0.56 in Q4 2024, 0.83 for Q4 2024, and 0.86 during Q3 2024.